Medical Weight Loss for Reno, Nevada Residents
Reno, Nevada residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Reno through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Reno Residents Choose New Hope Weight Loss
Reno patients choose New Hope Weight Loss because a named physician, Dr. Anjmun Sharma, M.D., oversees every case, pricing is transparent (semaglutide from $166/month, tirzepatide from $233/month · just $7.70/day), and the entire program runs by telehealth from our Costa Mesa, California clinic, which has served over 5,400 patients across Nevada and beyond since 2020.
Reno is served through telehealth from our Costa Mesa, California clinic. The consultation, prescription, and follow-up all happen by secure video, no travel required.
For Reno, medical weight loss is delivered online from our Costa Mesa, California practice, with no travel required. We care for patients throughout Downtown, Midtown, Old Southwest, Somersett, and the greater Truckee Meadows. There is no distance surcharge for Reno patients, and HSA, FSA, Klarna, and Affirm are all accepted.
Whether you live in central Reno or its outskirts, you get exactly the same care and the same price. We accept HSA, FSA, Klarna, and Affirm, with no mandatory membership and no surprise charges for Reno patients.
GLP-1 Weight Loss Programs Available
Compounded semaglutide, from $166/mo (90-day program $499)
The 90-day Metabolic Reset is our most-chosen plan. Semaglutide shares its active ingredient with Wegovy® and Ozempic®; in trials of the branded drug, patients lost an average of 15-17% of body weight under physician supervision.
Compounded tirzepatide, from $233/mo
Tirzepatide's dual GLP-1/GIP action reached up to 22.5% body-weight loss in trials of the branded medication, the advanced option for Reno patients.
The physician review is a flat $119, with medication billed separately; HSA, FSA, Klarna, and Affirm are accepted.
How Telehealth Works for Reno
Step 1: Complete the 2-minute quiz or the medical intake form online.
Step 2: Dr. Sharma reviews your history by secure video, typically within 48 hours.
Step 3: If you are a candidate and telehealth-eligible, the state-licensed 503(a) pharmacy ships your compounded medication to your Reno address in cold-pack packaging. Follow-ups and dose adjustments also happen by video, no travel required.
Frequently Asked Questions, Reno
How do I get treatment from Reno?
As a Reno, Nevada patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Reno?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Reno in cold-pack packaging, no lines and no drive.
How much does it cost for Reno patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Reno do you serve?
We serve patients from across Reno by telehealth, including Downtown, Midtown, Old Southwest, Somersett, and the greater Truckee Meadows.
How do Reno patients receive their medication?
After Dr. Sharma approves your protocol, the state-licensed 503(a) compounding pharmacy ships compounded semaglutide or tirzepatide directly to your Reno address in cold-pack packaging, part of the standard process, no distance surcharge.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Reno, Nevada by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.